Clinical trials for coronavirus have begun. First up: approved antivirals, malaria treatments and steroids

At least 31 clinical trials are under way to test therapeutic interventions for 2019-nCoV acute respiratory disease, according to ClinicalTrials.Gov and the Chinese Clinical Trial Register.

19 of the trials include a treatment arm testing an approved antiviral, including HIV drug Kaletra lopinavir/ritonavir from AbbVie Inc. (NYSE:ABBV) and Arbidol umifenovir, a flu therapy approved in China and Russia but not in the U.S...